Читать книгу Biologics, Biosimilars, and Biobetters - Группа авторов - Страница 90

Lantus^® was developed at Sanofi‐Aventis's biotechnology research center in Frankfurt‐Höchst, Germany.

Indication: Diabetes

Manufacturer: Sanofi

Global Sales in 2017: US$5.7 billion

Generic name: Insulin glargine [rDNA origin] injection

Launch date: 2000